Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
More noticeable effects typically appear within 2-4 weeks
InjectCo offers compounded semaglutide starting at $249 per month, or as low as $150 per month with 6-month financing through CareCredit or Cherry
Pfizer agreed to acquire all outstanding shares of Metsera common stock for $47.50 per share cash at closing, representing approximately $4.9 billion in enterprise value
In SURMOUNT-1 (Phase 3), tirzepatide at 15 mg produced 22.5% body weight loss at 72 weeks
Human evidence remains limited and exploratory
Platelet-rich plasma (PRP) therapy: Some emerging evidence exists, but PRP is not currently recommended by NICE and NHS availability is variable
US$ 28.50
US$ 26.46
US$ 25.57
US$ 24.00
US$ 27.60
US$ 28.02
